{
    "Trade/Device Name(s)": [
        "FreeStyle Libre 2 Flash Glucose Monitoring System",
        "FreeStyle Libre 2 App"
    ],
    "Submitter Information": "Abbott Diabetes Care Inc.",
    "510(k) Number": "K201761",
    "Predicate Device Reference 510(k) Number(s)": [
        "K193371",
        "K202145"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QLG",
        "NBW"
    ],
    "Summary Letter Date": "July 30, 2021",
    "Summary Letter Received Date": "December 23, 2020",
    "Submission Date": "December 21, 2020",
    "Regulation Number(s)": [
        "21 CFR 862.1355",
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Integrated continuous glucose monitoring system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Interstitial fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FreeStyle Libre 2 Sensor",
        "FreeStyle Libre 2 Reader",
        "iOS smartphone with FreeStyle Libre 2 App"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric measurement",
        "Electrochemical glucose oxidase reaction",
        "RFID communication",
        "Bluetooth Low Energy (BLE)",
        "Near Field Communication (NFC)"
    ],
    "Methodologies": [
        "Continuous glucose monitoring"
    ],
    "Submission Type(s)": [
        "System",
        "Sensor",
        "App",
        "Reader"
    ],
    "Document Summary": "FDA 510(k) summary for FreeStyle Libre 2 Flash Glucose Monitoring System and App for continuous interstitial fluid glucose measurement in diabetic patients age 4 and older.",
    "Indications for Use Summary": "Continuous glucose monitoring device with real time alarms for management of diabetes in persons age 4 and older, intended to replace blood glucose testing for treatment decisions, aids in detecting hyperglycemia and hypoglycemia, and can communicate with digitally connected devices.",
    "fda_folder": "Clinical Chemistry"
}